跳至主要内容
临床试验/NCT00121329
NCT00121329已完成不适用

4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions

Oregon Health and Science University2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2005年7月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
VAS scores during cervical dilation and uterine aspiration

研究概览

简要总结

Recent studies have investigated the use of local anesthetics (i.e. lidocaine, mepivacaine) to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy and office hysteroscopy. Local anesthetic injected into the uterine cavity has been demonstrated effective in some studies at decreasing patient pain associated with these intrauterine procedures at an anesthetic concentration of at least 2%. Based on this evidence, we hypothesized that an intrauterine lidocaine infusion may reduce patient pain during first trimester abortions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age > 18 years old
  • Good general health
  • English speaking
  • Confirmation of gestational age by ultrasound
  • Body weight > 100 lbs.
  • Pregnancy < 11 weeks

排除标准

  • 未提供

结局指标

主要结局

VAS scores during cervical dilation and uterine aspiration

次要结局

  • Patient satisfaction, symptoms, lidocaine levels

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验